GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 25 filers reported holding GEMPHIRE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $11,000 | -54.2% | 30,080 | 0.0% | 0.00% | – |
| Q2 2019 | $24,000 | -31.4% | 30,080 | 0.0% | 0.00% | – |
| Q1 2019 | $35,000 | +45.8% | 30,080 | 0.0% | 0.00% | – |
| Q4 2018 | $24,000 | -61.3% | 30,080 | 0.0% | 0.00% | – |
| Q3 2018 | $62,000 | -79.8% | 30,080 | 0.0% | 0.00% | – |
| Q2 2018 | $307,000 | +56.6% | 30,080 | 0.0% | 0.00% | – |
| Q1 2018 | $196,000 | +34.2% | 30,080 | +63.7% | 0.00% | – |
| Q4 2017 | $146,000 | +43.1% | 18,372 | +70.6% | 0.00% | – |
| Q3 2017 | $102,000 | – | 10,772 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exchange Capital Management, Inc. | 758,623 | $7,966,000 | 2.88% |
| Cormorant Asset Management, LP | 952,798 | $10,004,000 | 1.45% |
| DAFNA Capital Management LLC | 52,797 | $554,000 | 0.47% |
| HIGHLAND CAPITAL MANAGEMENT LP | 316,789 | $3,326,000 | 0.17% |
| Cambridge Investment Research Advisors, Inc. | 150,564 | $1,581,000 | 0.03% |
| NORRIS PERNE & FRENCH LLP/MI | 10,463 | $110,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 634,246 | $6,660,000 | 0.02% |
| SEGALL BRYANT & HAMILL, LLC | 11,000 | $116,000 | 0.00% |
| Acrospire Investment Management LLC | 400 | $4,000 | 0.00% |
| Advisor Group, Inc. | 5,112 | $54,000 | 0.00% |